We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Sepsis Therapeutic Device Cleans Infected Blood

By HospiMedica International staff writers
Posted on 07 Sep 2015
Print article
Image: The FcMBL blood-cleansing device (Photo courtesy of Wyss Institute at Harvard University).
Image: The FcMBL blood-cleansing device (Photo courtesy of Wyss Institute at Harvard University).
A novel blood-cleansing device based on a genetically engineered pathogen-capturing protein works by mimicking spleen function.

Developed by researchers at the Wyss Institute for Biologically Inspired Engineering (Boston, MA, USA), the sepsis device uses an innovative blood-cleansing approach that harnesses a proprietary pathogen-capturing agent called antibody Fc Mannose Binding Lectin (FcMBL), which binds all types of live and dead infectious microbes, including bacteria, fungi, viruses, and the endotoxins they release. As a universal device, it can be put into use quickly, even without identifying the infectious agent involved.

The concept is similar to that of a dialysis machine; infected blood is drawn from a vein through to the device, where FcMBL-coated magnetic beads are added to the blood. The pathogen-loaded beads are extracted by magnets within the device before the cleansed blood is returned to the body. The system uses commercial polysulfone or polyethersulfone cartridges coated with FcMBL. In animal studies the pathogen-extracting device reduced the number of E. coli, Staphylococcus aureus, and endotoxins circulating in the bloodstream by more than 99%. The device is described in the October 2015 of Biomaterials.

“The most effective strategy is to treat with the best antibiotics you can muster, while also removing the toxins and remaining pathogens from the patient's blood as quickly as possible,” said Donald Ingber, MD, PhD, founding director of the Wyss Institute. “Our goal is to see this move out of the lab and into hospitals as well as onto the battlefield, where it can save lives within years rather than decades.”

“If all goes well, physicians will someday be able to use the device in tandem with standard antibiotic treatments to deliver a one-two punch to pathogens, synergistically killing and cleansing all live and dead invaders from the bloodstream,” said lead author postdoctoral fellow Tohid Fatanat Didar, PhD. “Using the device, alone or alongside antibiotics, we can quickly bring blood back to normal conditions, curtailing an inflammatory response rather than exacerbating it.”

FcMBL is a genetically engineered blood protein inspired by a naturally-occurring human molecule called Mannose Binding Lectin (MBL), which is found in the innate immune system and binds to toxic invaders, marking them for capture by immune cells in the spleen.

Related Links:

Wyss Institute for Biologically Inspired Engineering


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Transcatheter Heart Valve
SAPIEN 3 Ultra
New
Mattress Replacement System
Carilex DualPlus

Print article

Channels

Surgical Techniques

view channel
Image: (Left) An image of a 3D-printed material implanted in vivo for 4 weeks. (Right) A photo of coral (Photo courtesy of Dr Zhidao Xia and Jesus Cobaleda)

Revolutionary Coral-Inspired Material for Bone Repair Promotes Faster Healing

Bone defects caused by fractures, tumors, and non-healing injuries are major contributors to disability worldwide. Traditionally, doctors have used either a patient’s own bone (autograft) or donor bone... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.